Steve Schonfeld’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-24,000
Closed -$8.71M – 2611
2021
Q3
$8.71M Buy
+24,000
New +$7.85M 0.09% 293

Other funds holding ONC

Steve Schonfeld's ONC Position: Q3 2026 in Review

Steve Schonfeld increased its BeOne Medicines (ONC) stake by 467% in Q3 2026, buying an estimated $3.09M and bringing the position to 10,962 shares worth $4.01M. The position accounts for 0.02% of the portfolio, ranked #781.

Steve Schonfeld first reported a position in ONC in Q4 2019 and has held it in 9 quarters since. The position peaked at $14M in Q1 2025. 325 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Steve Schonfeld held 10,962 shares of BeOne Medicines worth $4.01M as of Q3 2026.
  • Steve Schonfeld bought 9,030 BeOne Medicines shares in Q3 2026, an estimated $3.09M.
  • BeOne Medicines made up 0.02% of Steve Schonfeld's portfolio in Q3 2026, its #781 holding.
  • Steve Schonfeld first reported a position in BeOne Medicines in Q4 2019 and has held it in 9 quarters since.
  • Steve Schonfeld's BeOne Medicines position peaked at $14M in Q1 2025.
  • 325 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.